{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:35:47Z","timestamp":1790742947955,"version":"4.1.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/wnf.0b013e3182741c39","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T10:46:07Z","timestamp":1351853167000},"page":"269-272","source":"Crossref","is-referenced-by-count":13,"title":["Tolerability Profile of Clonidine in the Treatment of Adults With Tourette Syndrome"],"prefix":"10.1097","volume":"35","author":[{"given":"Andrea Eugenio","family":"Cavanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Selvini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Termine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Balottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare M.","family":"Eddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-3-20210203","doi-asserted-by":"crossref","first-page":"100","DOI":"10.12968\/hmed.2011.72.2.100","article-title":"Gilles de la Tourette syndrome: the complexities of phenotype and treatment.","volume":"72","author":"Robertson","year":"2011","journal-title":"Br J Hosp Med"},{"key":"R3-3-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/jnp.2009.21.1.13","article-title":". The behavioral spectrum of Gilles de la Tourette syndrome.","volume":"21","author":"Cavanna","year":"2009","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R4-3-20210203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1756285610390261","article-title":"Treatment strategies for tics in Tourette syndrome.","volume":"4","author":"Eddy","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"key":"R5-3-20210203","first-page":"150","article-title":". Pediatric psychopharmacology: psychopharmacology of tic disorders.","volume":"17","author":"Srour","year":"2008","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"R6-3-20210203","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"Roessner V, Plesse KJ, Rothenberger A, et al.. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.","volume":"20","author":"The ESSTS Guidelines","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"R7-3-20210203","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11940-010-0095-4","article-title":"Treatment of tics and Tourette syndrome.","volume":"12","author":"Singer","year":"2010","journal-title":"Current Treat Options Neurol"},{"key":"R8-3-20210203","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/archpsyc.1983.01790100081011","article-title":"Treatment of Gilles de la Tourettes syndrome with clonidine and neuroleptics.","volume":"40","author":"Shapiro","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"R9-3-20210203","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00004583-198403000-00008","article-title":". Growth hormone response to clonidine in children ages 4-17: Tourettes syndrome vs children with short stature.","volume":"23","author":"Leckman","year":"1984","journal-title":"J Am Acad Child Psychiatry"},{"key":"R10-3-20210203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000120222","article-title":"Haloperidol, fluphenazine and clonidine in Tourette syndrome: controversies in treatment.","volume":"12","author":"Singer","year":"1985","journal-title":"Pediatr Neurosci"},{"key":"R11-3-20210203","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1542\/peds.95.1.74","article-title":". The treatment of attention-deficit hyperactivity disorder in Tourettes syndrome: a double-blind placebo-controlled study with clonidine and desipramine.","volume":"95","author":"Singer","year":"1995","journal-title":"Pediatrics"},{"key":"R12-3-20210203","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF00314429","article-title":"Tourette syndrome: successful treatment with clonidine and oxycodone.","volume":"233","author":"Sandyk","year":"1986","journal-title":"J Neurol"},{"key":"R13-3-20210203","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1017\/S0317167100038087","article-title":"Motor behavioural and pharmacologic findings in Tourettes syndrome.","volume":"14","author":"Jankovic","year":"1987","journal-title":"J Can Neurol Sci"},{"key":"R14-3-20210203","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1212\/WNL.37.12.1828","article-title":"Treatment of Gilles de la Tourettes syndrome: eight-year, practice-based experience in a predominantly adult population.","volume":"37","author":"Marsel-Mesulam","year":"1987","journal-title":"Neurology"},{"key":"R15-3-20210203","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00004583-199007000-00026","article-title":". The clonidine patch and behaviour problems.","volume":"29","author":"Comings","year":"1990","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R16-3-20210203","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/088307389601100205","article-title":"Predictors of clonidine response in Tourette syndrome: implications and inferences.","volume":"11","author":"Lichter","year":"1996","journal-title":"J Child Neurol"},{"key":"R17-3-20210203","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1176\/jnp.2.1.66","article-title":"Treatment of Tourettes syndrome with transdermal clonidine: a pilot study.","volume":"2","author":"Gancher","year":"1990","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R18-3-20210203","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/088307380101600515","article-title":"Clonidine treatment increases tics in patients with Tourette syndrome: case report.","volume":"16","author":"Kessler","year":"2001","journal-title":"J Child Neurol"},{"key":"R19-3-20210203","first-page":"391","article-title":". Clonidine in the treatment of Tourette syndrome: a review of data.","volume":"35","author":"Leckman","year":"1982","journal-title":"Adv Neurol"},{"key":"R20-3-20210203","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/(SICI)1234-988X(199612)6:4<203::AID-MPR165>3.3.CO;2-F","article-title":"The National Hospital interview schedule for the assessment of Giles de la Tourette syndrome.","volume":"6","author":"Robertson","year":"1996","journal-title":"Int J Methods Psychiatr Res"},{"key":"R21-3-20210203","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.58.4.527","article-title":"Treatment of ADHD in children with tics. A randomized controlled trial.","volume":"58","year":"2002","journal-title":"Neurology"},{"key":"R22-3-20210203","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/00048670802277222","article-title":". Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders.","volume":"42","author":"Du","year":"2008","journal-title":"Aus N Z J Psych"},{"key":"R23-3-20210203","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0002-7138(09)61504-1","article-title":". Acute and chronic clonidine treatment in Tourettes syndrome: a preliminary report on clinical response and effect on plasma and urinary catecholamine metabolites, growth hormone, and blood pressure.","volume":"22","author":"Leckman","year":"1983","journal-title":"J Am Acad Child Psychiatry"},{"key":"R24-3-20210203","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.1991.01810280040006","article-title":". Clonidine treatment of Gilles de la Tourette syndrome.","volume":"48","author":"Leckman","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"R25-3-20210203","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00004583-200203000-00013","article-title":". Risperidone versus clonidine in the treatment of children and adolescents with Tourettes syndrome.","volume":"41","author":"Gaffney","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0b013e3182741c39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T20:18:07Z","timestamp":1643573887000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201211000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3182741c39","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}